(Total Views: 423)
Posted On: 10/07/2020 11:07:12 AM
Post# of 148902
Food for thought- experimental drug trial
1. patient either severe/critical doctors already prescribe SOC not making much improvement enroll in Leronlimab trial.
2. Patent receives either placebo 33.3% or 65 of them and they have a very hard time improving on just SOC and unfortunately many of them
Die. 66.6% or 130 receive Leronlimab in addition to Whatever SOC they were on and most of them improve and are living after 28 days.
3. Some patients may have tons of Underlying conditions so leronlimab is not going to save everyone as no drug will. However I am very positive that we will knock it put of the park with our mortality reduction %
1. patient either severe/critical doctors already prescribe SOC not making much improvement enroll in Leronlimab trial.
2. Patent receives either placebo 33.3% or 65 of them and they have a very hard time improving on just SOC and unfortunately many of them
Die. 66.6% or 130 receive Leronlimab in addition to Whatever SOC they were on and most of them improve and are living after 28 days.
3. Some patients may have tons of Underlying conditions so leronlimab is not going to save everyone as no drug will. However I am very positive that we will knock it put of the park with our mortality reduction %
(1)
(0)Scroll down for more posts ▼
